Mahana Therapeutics Obtains FDA Marketing Authorization for the First Prescription Digital Therapeutic to Treat Irritable Bowel Syndrome

Freespira Finalizes $10 Million Financing to Support Commercialization of Digital Therapeutic for Treatment of Panic Disorder and PTSD

New DarioHealth Study Shows Increased Digital Therapeutics Engagement Leads to Marked Reduction in Blood Glucose, Lower High Readings among Type 2 Diabetic Seniors

Lucine raises €5.5 million to develop a digital therapy to relieve and treat patients with chronic diseases.

Pear Therapeutics Launches Somryst™ for Chronic Insomnia via an End-to-End Virtual Care Experience

Voluntis Receives CE Mark for Oleena, Key Milestone to the Future Commercialization of its Digital Therapeutics for Oncology

Researchers Present New Outcome Data for Akili Digital Therapeutic EndeavorRx™ in Pediatric ADHD

Cognoa moves ahead on FDA clearance of digital autism diagnostic

Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia